Levitra is an oral medicine containing vardenafil for adult men with erectile dysfunction. It is used when needed and supports penile blood flow through PDE5 inhibition during sexual stimulation.
Levitra is a prescription treatment for erectile dysfunction, a condition involving difficulty achieving or maintaining an erection suitable for sexual activity. Vardenafil is the pharmacologically active substance associated with Levitra. It belongs to the PDE5 inhibitor group, which also includes medicines containing sildenafil, tadalafil, and avanafil. Regulatory information from the EMA describes vardenafil as a treatment that improves erectile response by supporting the natural blood-flow process in penile tissue [1].
Levitra is an oral medicine containing vardenafil, a pharmacologically active substance in the PDE5 inhibitor group. Levitra tablets are swallowed with water.
Levitra tablets are taken by mouth when needed for sexual activity. The exact strength and dose should follow the prescription issued for the individual patient. Treatment is not intended for repeated unsupervised dosing within the same day.
Practical administration points include:
Patients with kidney or liver impairment may require a lower starting dose or closer supervision. Older age, cardiovascular disease, and the use of interacting medicines can also change the safest regimen.
Sexual stimulation causes nerves in the penis to release nitric oxide. Nitric oxide increases cyclic GMP inside smooth muscle cells in the corpus cavernosum, the erectile tissue that fills with blood.
Vardenafil inhibits PDE5. This allows cyclic GMP to remain active for longer, supporting relaxation of the smooth muscle and increased arterial blood flow. The corporal tissue expands, compressing veins that normally drain blood from the penis, which helps maintain the erection.
The medicine does not work as an aphrodisiac. It does not increase sexual desire, and it cannot produce an erection without sexual stimulation. This distinction prevents a common misunderstanding.
The PDE5 pathway is also present in blood vessels elsewhere in the body. That explains possible effects such as headache, facial flushing, nasal congestion, light-headedness, and a temporary fall in blood pressure. The FDA prescribing information describes this mechanism and the main cardiovascular precautions [2].
The treatment goal is functional, predictable erectile response rather than continuous erection. It does not protect against sexually transmitted infections and does not replace contraception.
| Active ingredient | Typical clinical profile | Main practical distinction |
|---|---|---|
| Vardenafil | Taken when needed; sexual stimulation remains necessary | A high-fat meal may delay absorption; nitrate use is contraindicated |
| Sildenafil | Taken when needed; supports erections during stimulation | A heavy meal may delay onset; visual colour changes can occur |
| Tadalafil | Longer duration than many other PDE5 inhibitors | The longer exposure can be useful for spontaneity but may prolong adverse effects |
| Avanafil | Often selected when a faster onset is desired | Interaction and cardiovascular precautions still apply |
Vardenafil may suit a man who wants an on-demand PDE5 inhibitor and has previously experienced an inadequate response with another option. Tadalafil may be considered when a longer window of responsiveness is preferred. Sildenafil remains a widely used comparator, while avanafil may be considered when onset characteristics are a priority. The choice depends on cardiovascular status, other medicines, meal patterns, and previous tolerability. A clinical review in The Cochrane Database of Systematic Reviews found that PDE5 inhibitors improve erectile function compared with placebo, while tolerability and individual response vary [5].
Levitra is not suitable for everyone. The most serious interaction involves nitrate medicines, because the combination can cause a dangerous fall in blood pressure.
Never combine vardenafil with nitrates. The interaction may produce profound hypotension, collapse, or reduced blood flow to vital organs.
Alpha-blockers such as prazosin, terazosin, Hytrin, or Flomax can also lower blood pressure. Combining them with a PDE5 inhibitor may cause dizziness or fainting, especially after the first dose or after a dose increase. A prescriber may adjust the timing, dose, or choice of treatment.
Strong CYP3A4 inhibitors can increase vardenafil exposure. Examples include ritonavir and ketoconazole. Other medicines in this interaction group may include certain antifungal or antibiotic treatments. The product information advises dose restrictions or avoidance depending on the interacting medicine [4].
This medicine may not be right for you if you use nitrates or recreational nitrites, have serious heart problems, or have been told that sexual activity is unsafe. Tell the prescriber if you have low blood pressure, uncontrolled high blood pressure, stroke, kidney or liver disease, eye disease, bleeding disorders, or if you take alpha-blockers or other medicines for erectile dysfunction.
Headache, flushing, nasal congestion, indigestion, and dizziness are recognised adverse effects of vardenafil. They are often mild and temporary, although they can interfere with sexual activity or make standing uncomfortable. The frequency and severity depend on dose, health status, and interacting medicines.
| Effect pattern | Examples | Required response |
|---|---|---|
| Common, usually mild | Headache, flushing, nasal congestion, indigestion, dizziness | Rest, avoid alcohol, and seek medical advice if persistent or severe |
| Less common | Back pain, muscle discomfort, visual changes, palpitations | Stop activity and obtain clinical advice if symptoms continue |
| Urgent | Chest pain, fainting, sudden vision loss, sudden hearing loss, severe allergic reaction, priapism | Obtain urgent medical attention |
Priapism is an erection lasting longer than four hours. It is an emergency because prolonged trapped blood can damage erectile tissue. Do not wait for it to resolve without medical assessment.
Sudden loss of vision or hearing requires urgent evaluation. Chest pain during or after sexual activity also needs immediate attention, especially in someone with known heart disease.
A small number of patients describe a blue or altered colour tinge to vision. Any visual change that is sudden, marked, or persistent requires prompt medical attention. The EMA safety information identifies these rare but serious reactions alongside the more frequent headache and flushing effects [3].
A practical consultation should include all medicines, including occasional tablets, herbal products, recreational substances, and medicines bought without a prescription. Interaction risk can be missed when only regular prescriptions are discussed.
In clinical practice, doctors usually assess erectile dysfunction as a possible symptom of cardiovascular, metabolic, neurological, hormonal, or psychological disease. High blood pressure, diabetes, obesity, smoking, depression, and vascular disease can all contribute to erection problems.
A doctor will also ask about exertional chest pain. Sexual activity increases physical exertion, so an unrecognised heart problem can make erectile dysfunction treatment unsafe. The medicine should be selected after reviewing nitrates, alpha-blockers, blood-pressure treatment, and other interacting drugs.
Patients sometimes judge a PDE5 inhibitor after one unsatisfactory attempt. That can be misleading. Timing, a heavy meal, insufficient stimulation, anxiety, alcohol, and an unsuitable dose can all affect the result. Repeated failure deserves a treatment review rather than automatic dose escalation.
Vardenafil improves the vascular part of an erection. It does not treat relationship distress, severe performance anxiety, low testosterone, penile anatomical problems, or untreated depression. Those factors may need separate assessment.
No. Levitra supports the physiological response to sexual stimulation rather than creating sexual desire or an automatic erection. The PDE5 mechanism requires activation of the nitric oxide and cyclic GMP pathway. EMA product information describes this treatment as dependent on sexual arousal, and that principle remains relevant in 2026.
The onset varies with dose, food, health status, and individual absorption. A heavy meal may delay the response, while anxiety or insufficient stimulation may make the medicine seem ineffective. The 2011 FDA prescribing information describes vardenafil as an on-demand treatment rather than a continuous daily stimulant, and patients should follow the prescribed timing.
Alcohol may increase dizziness, flushing, low blood pressure, and difficulty achieving an erection. A small amount may be tolerated by some adults, while heavier drinking can reduce the practical benefit. WHO cardiovascular-risk guidance supports limiting alcohol where blood pressure and sexual function are concerns, including in 2026.
Some blood-pressure medicines can be combined only after the prescriber reviews the full regimen. Alpha-blockers such as prazosin, Hytrin, and Flomax can produce additional blood-pressure lowering, especially when treatment begins. The 2020 SAHPRA safety principles require careful review of interacting medicines, and dizziness or fainting should prompt urgent clinical advice.
No. Nitrates and vardenafil can cause a severe, potentially dangerous fall in blood pressure. This includes nitrate tablets, sprays, patches, and recreational nitrites known as poppers. The European Medicines Agency identifies nitrate co-administration as a contraindication, and the same warning applies to treatment decisions made in 2026.
An erection lasting more than four hours may be priapism and requires emergency treatment. Waiting at home can lead to permanent erectile-tissue injury. Clinical emergency guidance referenced by the American Urological Association in 2024 treats prolonged erection as time-sensitive, regardless of the prescribed tablet strength.
Diabetes-related blood-vessel and nerve changes can contribute to erectile dysfunction, and some men with diabetes respond to PDE5 inhibitors. Response may be less predictable when diabetes is poorly controlled or when cardiovascular disease is present. A 2025 review indexed in PubMed supports individual assessment of erectile dysfunction alongside diabetes control, cardiovascular risk, and current medicines.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
The first attempt was disappointing because I had eaten a large meal and was nervous. The next two attempts were more predictable when I used less alcohol and allowed time for arousal. Mild flushing was noticeable but passed.
Erection quality improved enough for intercourse, which reduced pressure in the relationship. Headaches occurred during the first few uses and became less bothersome later. I still needed to plan around meals.
The medicine helped, but dizziness made me uncomfortable when I stood up quickly. A review of my blood-pressure tablets was needed before continuing. It was useful, though not effortless.
